Lead Ventures Inc Share Price Canadian Securities Exchange
Equities
LEAD
CA5542341048
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -.--% | -37.50% |
30/04 | INSTANT VIEW-Biden administration plans to reclassify marijuana | RE |
30/04 | DEA to Move to Reclassify Marijuana, Associated Press Reports | MT |
Sales 2024 * | 1.41B 1.94B 118B | Sales 2025 * | 1.55B 2.14B 130B | Capitalization | 4.64B 6.39B 387B |
---|---|---|---|---|---|
Net income 2024 * | -107M -147M -8.93B | Net income 2025 * | -8M -11.02M -668M | EV / Sales 2024 * | 3.63 x |
Net Debt 2024 * | 474M 653M 39.57B | Net Debt 2025 * | 802M 1.1B 66.92B | EV / Sales 2025 * | 3.5 x |
P/E ratio 2024 * |
-42.7
x | P/E ratio 2025 * |
-93.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.68% |
Latest transcript on Lead Ventures Inc
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+188.32% | 2.69B | |
+144.44% | 80.19M |
- Stock Market
- Equities
- CURA Stock
- LEAD Stock